Active substance
Rizatriptan
- SFDA 6
- US FDA 31
- Health Canada 34
- US price lines 6
- NHS prices 8
- Safety 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Orziban | 10 mg | Orodispersible tablet · Oral use | 6 Blister | SAR 150.70 | Generic · Prescription | MS Pharma Saudi (MSPS) | Valid |
| REZMYG | 10 mg | Orodispersible tablet · Oral use | 18 Blister | SAR 80.65 | Generic · Prescription | Panacea Biotec Pharma Ltd | Valid |
| REZMYG | 5 mg | Orodispersible tablet · Oral use | 18 Blister | SAR 78.25 | Generic · Prescription | Panacea Biotec Pharma Ltd | Valid |
| MAXALT 10MG ORAL TABLET | 10 mg | Tablet · Oral use | 3 Blister | SAR 113.80 | NCE · Prescription | MERCK SHARP & DOHME | Withdrawn by MAH · Not Marketed |
| MAXALT 5MG ORAL TABLET | 5 mg | Tablet · Oral use | 3 Blister | SAR 110.90 | NCE · Prescription | MERCK SHARP & DOHME | Withdrawn by MAH · Not Marketed |
| MAXALT-MELT 10MG ORALLY DISINTEGRATING TABLET | 10 mg | Tablet · Oral use | 3 Box | SAR 106.50 | NCE · Prescription | MERCK SHARP & DOHME | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
MIGRAINE/ HEADACHE
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| MAXALT | EQ 10MG BASE | tablet · oral | ORGANON LLC | Prescription | 29 Jun 1998 |
| MAXALT-MLT | EQ 10MG BASE | tablet, orally disintegrating · oral | ORGANON | Prescription | 29 Jun 1998 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | TEVA PHARMS | Prescription | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | PHARMAZONE | Prescription | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | CHARTWELL RX | Prescription | 26 Mar 2013 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | AUROBINDO PHARMA LTD | Prescription | 1 Jul 2013 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | MACLEODS PHARMS | Prescription | 11 Feb 2014 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | MACLEODS PHARMS LTD | Prescription | 19 Sep 2014 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | ALKEM LABS LTD | Prescription | 18 Feb 2016 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | PANACEA | Prescription | 11 Jan 2017 |
| RIZAFILM | EQ 10MG BASE | film · oral | GENSCO | Prescription | 14 Apr 2023 |
| MAXALT | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ORGANON LLC | Discontinued | 29 Jun 1998 |
| MAXALT-MLT | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, orally disintegrating · oral | ORGANON | Discontinued | 29 Jun 1998 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | PHARMOBEDIENT | Discontinued | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | SANDOZ | Discontinued | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | NATCO PHARMA LTD | Discontinued | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | GLENMARK PHARMS LTD | Discontinued | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | PHARMOBEDIENT | Discontinued | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | APOTEX INC | Discontinued | 31 Dec 2012 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | CHARTWELL RX | Discontinued | 1 Jul 2013 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | GLENMARK PHARMS LTD | Discontinued | 1 Jul 2013 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | APOTEX INC | Discontinued | 1 Jul 2013 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet, orally disintegrating · oral | NATCO PHARMA LTD | Discontinued | 1 Jul 2013 |
| RIZATRIPTAN BENZOATE | EQ 5MG BASE; EQ 10MG BASE | tablet · oral | INVAGEN PHARMS | Discontinued | 1 Jul 2013 |
6 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACCEL-RIZATRIPTAN ODT | 02483270 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ACCEL PHARMA INC |
| ACCEL-RIZATRIPTAN ODT | 02483289 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ACCEL PHARMA INC |
| ACT RIZATRIPTAN | 02381702 | 10 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| AG-RIZATRIPTAN ODT | 02492482 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ANGITA PHARMA INC. |
| AG-RIZATRIPTAN ODT | 02492490 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ANGITA PHARMA INC. |
| APO-RIZATRIPTAN | 02393468 | 5 MG | TABLET · ORAL | APOTEX INC |
| APO-RIZATRIPTAN | 02393476 | 10 MG | TABLET · ORAL | APOTEX INC |
| JAMP RIZATRIPTAN | 02380463 | 10 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP-RIZATRIPTAN ODT | 02465086 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | JAMP PHARMA CORPORATION |
| JAMP-RIZATRIPTAN ODT | 02465094 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | JAMP PHARMA CORPORATION |
| M-RIZATRIPTAN | 02547716 | 10 MG | TABLET · ORAL | MANTRA PHARMA INC |
| M-RIZATRIPTAN ODT | 02548801 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | MANTRA PHARMA INC |
| M-RIZATRIPTAN ODT | 02548828 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | MANTRA PHARMA INC |
| MAR-RIZATRIPTAN | 02379678 | 10 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-RIZATRIPTAN ODT | 02462788 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-RIZATRIPTAN ODT | 02462796 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | MARCAN PHARMACEUTICALS INC |
| MAXALT | 02240521 | 10 MG | TABLET · ORAL | ORGANON CANADA INC. |
| MAXALT RPD | 02240518 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ORGANON CANADA INC. |
| MAXALT RPD | 02240519 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | ORGANON CANADA INC. |
| MYLAN-RIZATRIPTAN ODT | 02379198 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | MYLAN PHARMACEUTICALS ULC |
| MYLAN-RIZATRIPTAN ODT | 02379201 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | MYLAN PHARMACEUTICALS ULC |
| PMS-RIZATRIPTAN RDT | 02393360 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | PHARMASCIENCE INC |
| PMS-RIZATRIPTAN RDT | 02393379 | 10 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | PHARMASCIENCE INC |
| RIZATRIPTAN | 02516756 | 10 MG | TABLET · ORAL | SANIS HEALTH INC |
| RIZATRIPTAN ODT | 02442906 | 5 MG | TABLET (ORALLY-DISINTEGRATING) · ORAL | SANIS HEALTH INC |
9 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | MAXALT 10 MG TABLET | $44.4765 | per EA | 1 Jan 2026 |
| US NADAC | MAXALT MLT 10 MG TABLET | $44.21394 | per EA | 23 Sep 2026 |
| US NADAC | RIZATRIPTAN 10 MG ODT | $0.50969 | per EA | 23 Sep 2026 |
| US NADAC | RIZATRIPTAN 10 MG TABLET | $0.33545 | per EA | 23 Sep 2026 |
| US NADAC | RIZATRIPTAN 5 MG ODT | $0.54459 | per EA | 23 Sep 2026 |
| US NADAC | RIZATRIPTAN 5 MG TABLET | $0.34799 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Rizatriptan 10mg oral lyophilisates sugar free | £13.37 | 3 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 10mg oral lyophilisates sugar free | £26.74 | 6 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 10mg oral lyophilisates sugar free | £53.48 | 12 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 10mg orodispersible tablets sugar free | £4.16 | 3 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 10mg tablets | £5.38 | 3 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 5mg orodispersible tablets sugar free | £18.98 | 6 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 5mg orodispersible tablets sugar free | £37.96 | 12 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Rizatriptan 5mg tablets | £26.13 | 6 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 26 Feb 2026 RIZAFILM — safety-related labeling change
Labeling sections changed: Contraindications; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 1 Oct 2019 MAXALT — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations - US FDA 1 Oct 2019 MAXALT-MLT — safety-related labeling change
Labeling sections changed: Contraindications; Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.